Neogen Chemicals Completes ₹161 Crore Preferential Allotment to Cadamba Solutions
NiveshIQ
NSE: NEOGEN · Chemicals
NEOGEN CHEMICALS LTD.
₹2,373.00▼ ₹15.90 (-0.67%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on NEOGEN. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About NEOGEN CHEMICALS LTD.
Neogen Chemicals Limited is a specialty chemicals manufacturer in India, offering a range of products including organo bromine compounds, specialty chloro compounds, and organo lithium compounds. The company's core business is driven by the demand for these specialty chemicals, which are used in various industries such as pharmaceuticals, agrochemicals, and electronics. Recently, Neogen Chemicals reported a 34% increase in revenue to ₹250 crore in Q1 FY27, driven by strong demand for its products. The company plans to raise ₹600 crore through a qualified institutional placement (QIP) to reduce its debt and enhance its financial flexibility. Neogen Chemicals operates in a competitive market, but its focus on specialty chemicals and strong research and development capabilities position it we
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹691.00 Cr +0.70% | ₹777.56 Cr +12.50% | ₹861.96 Cr +10.90% |
| EBITDA Margin | 15.92% | 18.05% | 16.67% |
| Net Profit | ₹36.00 Cr -28.00% | ₹34.83 Cr -3.30% | ₹28.75 Cr -17.50% |
| EPS | ₹13.51 | ₹13.20 | ₹10.90 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Neogen Chemicals Completes ₹161 Crore Preferential Allotment to Cadamba Solutions
Neogen Chemicals Recovers to Hit Day High After QIP Move
🔒
+ 3 more stories about NEOGEN CHEMICALS LTD.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹250 Cr, PAT ₹17 Cr, EPS ₹6.29, EBITDA margin 20.8%. Growth context: revenue QoQ +1.5%, PAT QoQ +50.2%. Street verdict: strong beat, revenue surprise +9.2%, PAT surprise +67.6%.
Key drivers for Neogen over the next 2–4 quarters will be realisations, demand recovery, cost efficiency, capacity utili...
FY26 (last completed FY): revenue ₹862 Cr, PAT ₹29 Cr, EBITDA margin 16.7%, EPS ₹10.90. Year-on-year: revenue YoY +10.9%...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for NEOGEN
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track NEOGEN alongside your other holdings
Unlock full NEOGEN research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for NEOGEN CHEMICALS LTD.?
NiveshIQ detects active intelligence signals for NEOGEN CHEMICALS LTD. (NEOGEN) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for NEOGEN CHEMICALS LTD.?
NEOGEN CHEMICALS LTD. operates in the Chemicals sector with a market capitalisation of ₹483,286.5L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.